Aspira Women's Health Inc.
AWHL
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 3.53% | 0.31% | -2.33% | -1.21% | 4.46% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 3.53% | 0.31% | -2.33% | -1.21% | 4.46% |
Cost of Revenue | -5.89% | -4.86% | -3.60% | -3.54% | -8.82% |
Gross Profit | 10.11% | 4.12% | -1.40% | 0.57% | 16.31% |
SG&A Expenses | -8.63% | -8.00% | -13.25% | -23.43% | -29.60% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -8.21% | -9.09% | -10.49% | -21.10% | -28.56% |
Operating Income | 14.32% | 13.65% | 14.27% | 28.50% | 38.65% |
Income Before Tax | 30.00% | 21.55% | 18.67% | 24.99% | 45.80% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 30.00% | 21.55% | 18.67% | 24.99% | 45.80% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 30.00% | 21.55% | 18.67% | 24.99% | 45.80% |
EBIT | 14.32% | 13.65% | 14.27% | 28.50% | 38.65% |
EBITDA | 13.97% | 13.23% | 13.84% | 28.28% | 38.63% |
EPS Basic | 52.87% | 46.57% | 42.91% | 44.56% | 58.04% |
Normalized Basic EPS | 50.61% | 45.31% | 43.40% | 44.88% | 52.91% |
EPS Diluted | 52.87% | 46.57% | 42.96% | 44.66% | 58.10% |
Normalized Diluted EPS | 50.61% | 45.31% | 43.40% | 44.88% | 52.91% |
Average Basic Shares Outstanding | 63.81% | 53.09% | 44.24% | 35.73% | 26.73% |
Average Diluted Shares Outstanding | 63.81% | 53.09% | 44.24% | 35.73% | 26.73% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |